Study: Keloids linked to early onset and late stage breast cancer

January 24, 2019

DETROIT - Findings from a new study conducted by researchers at Henry Ford Health System suggest a link between keloids and increased risk of being diagnosed with breast cancer, particularly among African Americans. Keloids are benign fibroproliferative tumors, which can result in excessive growths of scar-like tissue on the skin. Keloids have been reported to affect some 11 million people worldwide. Despite this prevalence, the exact cause of keloid formation is unknown.

The multi-disciplinary research team hypothesized African American women with a history of keloids would reflect a population of breast cancer patients with aggressive tumors and poor outcomes. Medical record review of 13,033 patients with scar codes in the Henry Ford Health System electronic health record, between 2005-2015 was conducted.

Of these patients, 255 also had a concurrent breast cancer diagnosis. Of this group of 255 patients with a breast cancer diagnosis, 102 had a confirmed history of keloids and 152 did not have keloids. Using this patient cohort, the researchers conducted multivariate analysis to identify associations between breast cancer related clinical factors, and keloid status.

The researchers found a race-specific age association, with African American patients displaying significantly younger ages at breast cancer diagnosis in keloid-positive patients, average age 52-years-old, versus keloid-negative patients, average age 58-years-old. In addition, keloid patients had a larger percentage of late stage breast cancers (11.7% versus 4.8%). The group hypothesizes that ethnic variations in tumor immune response may underlie their unique cancer risk.

"It is well-documented that keloids and certain aggressive breast cancer such as triple negative and inflammatory types disproportionately affect African American Women," said Lamont R Jones, M.D., MBA, vice chair for the Department of Otolaryngology - Head and Neck Surgery at Henry Ford Health System, and principal investigator of this study. "We need to better understand how immune-related differences, specific to African Americans, result in more aggressive types of cancer. While the results of this study are preliminary, we believe further investigating a possible link between breast cancer and keloids may provide more insight."
-end-
The study is being presented at the Triological Society's Combined Section Meeting Jan. 24-26 in Coronado, California.

The research team consisted of Lamont R. Jones M.D., MBA, Edward M. Walton BS, Brittany D Jenkins Ph.D., Vanessa P. Chu, Haythem Y. Ali, M.D., Christine M Nesland-Dudas Ph.D., Eleanor M Walker Ph.D. and Melissa B. Davis, Ph.D.

Henry Ford Health System

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.